Dr. Gary Jennings
CSO and Co-Founder
Dr. Jennings has over 13 years experience in the commercial biotechnology industry. As a co-founder of JADO, Dr. Jennings led the company through its early start-up stages until August 2007. Recently he has become solely focused on spearheading the Company’s research and development efforts as Chief Scientific Officer. Previously, he gained industrial experience at Ribonetics GmbH and as Head of Cell Engineering at HepaVec AG (Berlin) and DeveloGen AG (Göttingen). As a trained biochemist he worked on liver carcinogenesis at the Institute of Toxicology, University of Mainz, Germany, before moving to the Max-Delbrück Center of Molecular Medicine (Berlin) to study tissue engineering. Dr. Jennings received his PhD from the University of York (UK). |